MedTrace Logo

Radiotherapy in Preoperative Setting With CyberKnife for Breast Cancer

NCT03520894 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2019-10-22

No results posted yet for this study

Summary

The aim of this study is to prospectively evaluate, in patients affected by early breast cancer, safety and feasibility of single fraction radiotherapy with Cyberknife R in preoperative setting, and to identify factors predictive for outcome based on biologic and clinical parameters.

Conditions

  • Early Breast Cancer

Interventions

RADIATION

Neoadjuvant radiotherapy

single 21 Gy fraction of Radiotherapy before surgery

Sponsors & Collaborators

  • Azienda Ospedaliero-Universitaria Careggi

    lead OTHER

Principal Investigators

  • Lorenzo Livi, Prof · AOU Careggi

  • Icro Meattini, Prof · AOU Careggi

  • Giulio Francolini, MD · AOU Careggi

  • Vanessa Di Cataldo, MD · AOU Careggi

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2022-05-01
Completion
2024-05-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03520894 on ClinicalTrials.gov